pretickt

When does ResMed report earnings?

ResMed Inc. · end-of-day data as of Nov 13, 2026

ResMed
RMD · $33.69B
$239.53+0.3%
Nov 13, 2026 · close
$220$240SepOctNov9:3016:003 months +9.5%Nov 13 · close
▲ 6
  • ConsensusBuy · 21
  • P/E vs sector-32.1%
  • FCF yield+8.5%
  • Trendbullish
  • MAs3 of 4
  • Sector▲ +15.9%
Neutral
  • Earnings in76d
  • P/E21.9x
  • RSI53
  • Support-4.7%
  • Resistance+0.6%
  • Off 52w high-13.7%
  • Volume0.6x
  • Bollingerlower half
  • News0.00
  • P/E vs own+3.6%
  • PT$251.42 +5.0%
  • 52w range$180–$278
  • ATR+3.0%
  • Off ATH-20.5%
▼ 2
  • Insiders-$3.74M
  • MACD-0.82

Updates with the 15-min delayed price. Not a forecast or investment advice.

ResMed RMD reports its next earnings on Thursday, Jan 28, 2027, after the close, an estimated date the company has not confirmed yet. Analysts expect EPS of $3.03 on revenue of $1.46B. ResMed beat the EPS estimate in 6 of its last 8 reports, and the stock moved ±5.2% on average the session after. The last report, on Oct 29, 2026: EPS of $2.91 against $2.69 expected and revenue of $1.41B against $1.39B; the stock fell 9.1% the next session.

The stock around its reports

⇔⇕$189$220$251$283Nov 24Apr 25Sep 25Feb 26Jul 26Dec 26EDAEDAEDEDAEDEDAAEDAEADE

Last close $239.53 · -1.7% over 2y · E earnings · D dividend · S split · A analyst rating change

Quarterly results

Q1 FY2027: Revenue +5.9% year over year, free cash flow 26.4% of revenue, operating margin 32.0%.

RevenueFree cash flow
Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Q1 FY2027Sep 30, 2026$1.41B2.92$374M61.5%32.0%29.6%
Q4 FY2026Jun 30, 2026$1.46B2.64$1.65B58.8%30.7%26.2%
Q3 FY2026Mar 31, 2026$1.43B2.71$520M62.2%34.9%27.9%
Q2 FY2026Dec 31, 2025$1.42B2.68$305M62.2%35.0%27.6%
Q1 FY2026Sep 30, 2025$1.34B2.37$414M61.5%33.4%26.1%
Q4 FY2025Jun 30, 2025$1.35B2.58$508M60.8%33.7%28.2%
Q3 FY2025Mar 31, 2025$1.29B2.48$555M59.3%33.0%28.3%
Q2 FY2025Dec 31, 2024$1.28B2.34$290M58.6%32.5%26.9%